Renal impairment and medication use among psychogeriatric inpatients

Canadian Journal of Clinical Pharmacology

Volumn 10, Issue 2, 2003, Pages 78-82

  Bédard, Michel ^a   Klein, Rupert ^a   Papaioannou, Alexandra ^b   Motyka, Sophia ^a   Hutchinson, Lois ^a   Clarke, Jo Anne ^a  

^a Lakehead Psychiatric Hospital   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Creatinine clearance; Medication use; Older adults; Renal function; Serum creatinine

Indexed keywords

ALLOPURINOL; ALUMINUM MAGNESIUM HYDROXIDE; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ATENOLOL; CAPTOPRIL; CILAZAPRIL; ENALAPRIL; FAMOTIDINE; GLIBENCLAMIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; MAGNESIUM HYDROXIDE; METFORMIN; NITROFURANTOIN; PERINDOPRIL; QUINAPRIL; RAMIPRIL; RANITIDINE; SPIRONOLACTONE;

AGED; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE REGIMEN; FEMALE; GERONTOPSYCHIATRY; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; PRACTICE GUIDELINE;

EID: 0041930998     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985;33:278-85.
2. Culleton BF, Larson MG, Evans JC, Wilson PW, et al. Barrett BJ, Parfrey PS, et al. Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study. Arch Intern Med 1999;159:1785-90.
3. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, et al. Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 1998;32:992-9.
4. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: A cross-sectional and longitudinal study. J Gerontol 1976;31:155-63.
5. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
6. Zubenko GS, Sunderland T. Geriatric pharmacology: Why does age matter? Harv Rev Psychiatry 2000;7:311-33.
7. Gral T, Young M. Measured versus estimated creatinine clearance in the elderly as an index of renal function. J Am Geriatr Soc 1980;28:492-6.
8. Friedman JR, Norman DC, Yoshikawa TT. Correlation of estimated renal function parameters versus 24-hour creatinine clearance in ambulatory elderly. J Am Geriatr Soc 1989;37:145-9.
9. Durakovic Z. Creatinine clearance in the elderly: A comparison of direct measurement and calculation from serum creatinine. Nephron 1986;44:66-9.
10. O'Connell MB, Dwinell AM, Bannick-Mohrland SD. Predictive performance of equations to estimate creatinine clearance in hospitalized elderly patients. Ann Pharmacother 1992;26:627-35.
11. Campbell G, Graham-Robinson N. Amantidine for influenza. Consultant Pharmacist 1999;15:41-5.
12. Pollow R, Stoller EP, Forster LE, Duniho TS. Drug combinations and potential for adverse drug reaction among community-dwelling elderly. Nurs Res 1994;43:44-9.
13. Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with cognitive impairment in elderly persons. Ann Intern Med 1987;107:169-73.
14. Starr JM, Whalley LJ. Drug-induced dementia: Incidence, management and prevention. Drug Saf 1994;11:310-7.
15. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991;114:956-66.
16. Jick H. Adverse drug effects in relation to renal function. Am J Med 1977;62:514-7.
17. Aronoff GR, Berns JS, Brier ME, et al. Drug prescribing in renal failure: Dosing guidelines for adults. 4th edn. Philadelphia: American College of Physicians, 1999.
18. Semla TP, Beizer JL, Higbee MD. Geriatric dosing handbook. 4th edn. Hudson: Lexi-Comp, 1998.
19. Canadian Pharmacological Association. Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmacological Association, 1999.
20. American Society of Health Systems Pharmacists. AHFS Drug information. Wisconsin: American Society of Health Systems Pharmacists, 1998.
21. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997;277:312-7.
22. McMullin ST, Reichley RM, Kahn MG, Dunagan WC, Bailey TC. Automated system for identifying potential dosage problems at a large university hospital. Am J Health Syst Pharm 1997;54:545-9.
23. Papaioannou A, Clarke J-O, Campbell G, Bédard M. Assessment of adherence to renal dosing guidelines in long term care facilities. J Am Geriatr Soc 2000;48:1470-3.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington: American Psychiatric Association, 1994.
25. Howell DC. Statistical methods for psychology, 2nd edn. Boston: Duxbury Press, 1987.
26. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
27. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
28. Morgan DB, Dillon S, Payne RB. The assessment of glomerular function: Creatinine clearance or plasma creatinine? Postgrad Med J 1978;54:302-10.
29. DeSanto NG, Coppola S, Anastasio P, et al. Predicted creatinine clearance to assess glomerular filtration rate in chronic renal disease in humans. Am J Nephrol 1991;11:181-5.
30. Robertshaw M, Lai KN, Swaminathan R. Prediction of creatinine clearance from plasma creatinine: Comparison of five formulae. Br J Clin Pharmacol 1989;28:275-80.
31. Toto RD. Conventional measurement of renal function utilizing serum creatinine, creatinine clearance, inulin and paraaminohippuric acid clearance. Curr Opin Nephrol Hypertens 1995;4:505-9.
32. Nicoll SR, Sainsbury R, Bailey RR, et al. Assessment of creatinine clearance in healthy subjects over 65 years of age. Nephron 1991;59:621-5.
33. Waller DG, Fleming JS, Ramsey B, Gray J. The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991;67:42-6.
34. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing. A randomized controlled trial. Med Care 1992;30:646-58.
35. Champagne MP. Renal disease audit and drug usage evaluation for all patients. Hosp Pharm 1992;27:1065-72.
36. Golightly LK, O'Fallon CL, Moran WD, Sorocki AH. Pharmacist monitoring of drug therapy in patients with abnormal serum creatinine levels. Hosp Pharm 1993;28:725-32.
37. Peterson JP, Colucci VJ, Schiff SE. Using serum creatinine concentrations to screen for inappropriate dosage of renally eliminated drugs. Am J Hosp Pharm 1992;48:1962-4.
38. Ho L, Brown GR, Millin B. Characterization of errors detected during central order review. Can J Hosp Pharm 1992;45:193-7.
39. McMullin ST, Reichley RM, Watson LA, Steib SA, Frisse ME, Bailey TC. Impact of a Web-based clinical information system on cisapride drug interactions and patient safety. Arch Intern Med 1999;159:2077-82.
40. Tamblyn RM, McLeod PJ, Abrahamowicz M, Laprise R. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potentially inappropriate drug combinations. CMAJ 1996;154:1177-84.
41. Greenblatt DJ. Basic pharmacokinetics principles and their application to psychotropic drugs. J Clin Psychiatry 1993;54(Suppl 1):8-13.
42. Zubenko GS, Marino LJJ, Sweet RA, Rifai AH, Mulsant BH, Pasternak RE. Medical comorbidity in elderly psychiatric inpatients. Biol Psychiatry 1997;41:724-36.